GoodRx Holdings, Inc. (GDRX)

NMS – Цена в реальном времени. Валюта: USD

2.69

-0.15 (-5.28%)

При закрытии: May 12, 2026, 4:00 PM EDT

2.83

+0.14 (5.20%)

После закрытия: May 12, 2026, 7:59 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

GoodRx Holdings, Inc. (GDRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

GoodRx Holdings, Inc. (GDRX)

GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript

Big Pharma Runs Its Checkout Counter Through GoodRx

Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?

GoodRx (GDRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates

GoodRx Reports First Quarter 2026 Results

Hims & Hers Expands Digital-First Access to Personalized Healthcare

Видео

No Data

Пресс-релизы

GoodRx Reports First Quarter 2026 Results

GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price

GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications

Search stocks

GoodRx Holdings, Inc. (GDRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

GoodRx Holdings, Inc. (GDRX)

GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript

Big Pharma Runs Its Checkout Counter Through GoodRx

Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?

GoodRx (GDRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates

GoodRx Reports First Quarter 2026 Results

Hims & Hers Expands Digital-First Access to Personalized Healthcare

Видео

No Data

Пресс-релизы

GoodRx Reports First Quarter 2026 Results

GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price

GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications